Diversification into the medtech sector represents a growth opportunity for many microtech companies. But how do you approach this transition? What are the challenges to be anticipated and the key success factors?
On the occasion of EPHJ, Micronarc and BioAlps invite you to a dedicated session featuring experts and company directors with concrete experience in this field. Marie Gaumet, Managing Director of SwAPP, will present medtech market opportunities and key features. Gilles Robert, CEO of MPS SA, and Grégory Dourde, CEO of Preciflex SA, will share their experiences of diversifying into this demanding but buoyant sector.
The session will conclude with a panel discussion and exchanges with the audience on the opportunities, challenges and key success factors of diversifying into medtech.
Free admission for show visitors